Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Two Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AXER-204 in Subjects With Chronic Spinal Cord Injury

NCT03989440 is registered in ClinicalTrials.gov with ReNetX Bio, Inc. as lead sponsor.

NCT NCT03989440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03989440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Two Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AXER-204 in Subjects With Chronic Spinal Cord Injury
Lead sponsor
ReNetX Bio, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
July 16, 2019
Completion date
June 21, 2022
Enrollment
52 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic spinal cord injury